Induction, Consolidation and Intensification Therapy for Patients Younger Than 66 Years With Previously Untreated CD33 Positive Acute Myeloid Leukemia (AML)

NCT00909168 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

130

Enrollment

OTHER

Sponsor class

Conditions

Acute Myeloid Leukemia

Interventions

DRUG: FLAIMy - Fluda, Ida, Ara-C, Mylotarg

Sponsor

University Hospital, Udine, Italy